Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer.
Farrow DC, Vaughan TL, Sweeney C, Gammon MD, Chow WH, Risch HA, Stanford JL, Hansten PD, Mayne ST, Schoenberg JB, Rotterdam H, Ahsan H, West AB, Dubrow R, Fraumeni JF Jr, Blot WJ.
Farrow DC, et al. Among authors: vaughan tl.
Cancer Causes Control. 2000 Mar;11(3):231-8. doi: 10.1023/a:1008913828105.
Cancer Causes Control. 2000.
PMID: 10782657